Cargando…
Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis
BACKGROUND: ATLL (Adult T-Cell Leukemia/Lymphoma) is an aggressive hematological malignancy. This T-cell non-Hodgkin lymphoma, caused by the human T-cell leukemia virus type 1 (HTLV-1), is challenging to treat. There is no known treatment for ATLL as of yet. However, it is recommended to use Zidovud...
Autores principales: | Shafiee, Arman, Seighali, Niloofar, Taherzadeh-ghahfarokhi, Nooshin, Mardi, Shayan, Shojaeian, Sorour, Shadabi, Shahrzad, Hasani, Mahsa, Haghi, Sabahat, Mozhgani, Sayed-Hamidreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249295/ https://www.ncbi.nlm.nih.gov/pubmed/37287047 http://dx.doi.org/10.1186/s12985-023-02077-0 |
Ejemplares similares
-
The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-Analysis of Clinical and Paraclinical Characteristics
por: Hasani, Hamidreza, et al.
Publicado: (2020) -
Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies
por: Seighali, Niloofar, et al.
Publicado: (2023) -
Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α
por: Hodson, Andrew, et al.
Publicado: (2014) -
Quality of Life and Related Paraclinical Factors in Iranian Patients with Transfusion-Dependent Thalassemia
por: Khodashenas, Mehran, et al.
Publicado: (2021) -
First line treatment of acute and chronic ATLL with zidovudine (AZT) and interferon alpha (IFN-α): haematological and molecular responses
por: Hodson, Andrew, et al.
Publicado: (2011)